Teza Capital Management LLC Acquires New Position in Encompass Health Co. (NYSE:EHC)

Teza Capital Management LLC bought a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 12,210 shares of the company's stock, valued at approximately $1,128,000.

Several other hedge funds have also recently bought and sold shares of EHC. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after purchasing an additional 137 shares during the last quarter. Colonial Trust Co SC acquired a new stake in shares of Encompass Health in the fourth quarter valued at approximately $29,000. Transce3nd LLC acquired a new stake in shares of Encompass Health in the fourth quarter valued at approximately $40,000. CBIZ Investment Advisory Services LLC raised its holdings in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after purchasing an additional 127 shares during the last quarter. Finally, V Square Quantitative Management LLC raised its holdings in shares of Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after purchasing an additional 177 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on EHC shares. William Blair reiterated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. KeyCorp lifted their price objective on shares of Encompass Health from $120.00 to $122.00 and gave the company an "overweight" rating in a report on Friday, April 25th. UBS Group lifted their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a report on Monday, April 28th. Truist Financial reissued a "buy" rating and issued a $135.00 target price (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Finally, Royal Bank of Canada raised their target price on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Eight equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $120.86.

Insiders Place Their Bets

In other news, CEO Mark J. Tarr sold 118,384 shares of the business's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the sale, the chief executive officer now owns 527,070 shares of the company's stock, valued at approximately $64,054,817.10. The trade was a 18.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the business's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total transaction of $498,974.19. Following the completion of the sale, the insider now directly owns 11,958 shares of the company's stock, valued at approximately $1,394,422.38. The trade was a 26.35% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 132,663 shares of company stock valued at $16,034,082 over the last ninety days. 2.00% of the stock is currently owned by company insiders.

Encompass Health Stock Up 0.1%

Shares of NYSE:EHC traded up $0.13 during midday trading on Friday, hitting $118.74. The stock had a trading volume of 388,011 shares, compared to its average volume of 699,207. Encompass Health Co. has a 12 month low of $82.74 and a 12 month high of $121.96. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The business's 50-day simple moving average is $107.85 and its 200-day simple moving average is $101.42. The company has a market cap of $11.97 billion, a P/E ratio of 26.62, a PEG ratio of 2.31 and a beta of 0.91.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The company reported $1.37 EPS for the quarter, topping analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The firm had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.43 billion. During the same period in the previous year, the business posted $1.12 earnings per share. The company's revenue for the quarter was up 10.6% compared to the same quarter last year. On average, sell-side analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a dividend of $0.17 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.57%. Encompass Health's dividend payout ratio (DPR) is 14.05%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.